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السياحة الطبية للخارج
حتدي جديد للنظام الصحي يف ُعمان:جتربة املنطقة الداخلية
�ضالح بن �ضيف الهنائي، اأحمد بن �ضعيد البو�ضعيدي، اإبراهيم بن هلل البو�ضعيدي
ونفقات،  م�ضاكل  من  ذلك  يتبع  ما  مع  ال�ضلطنة  خارج  يف  طبية  م�ضورة  عن  للبحث  النا�س  تدفع  التي  الأ�ضباب  معرفة  الهدف:  امللخ�ص: 
وتو�ضيح اأنواِع امل�ضاكِل الطبية والوجهات املف�ضلة والقناعة باملعاجلة يف اخلارج. الهدف الثانوي لهذه الدرا�ضة هو اإعطاء نبذة لأ�ضحاب 
القرار يف نظاِم الرعاية ال�ضحية عن َكيفية التعامل مع هذه الظاهرة مبا يلبي احتياجات املجتمع. الطريقة: مت توزيع ا�ضتبيان على 45 من 
املر�ضى الذين �ضافروا للعلج خارج ال�ضلطنة موؤخرا اأو باملقابلة الهاتفية. النتائج: مت ا�ضتلم 40 ا�ضتبيانا، 68% من امل�ضاركني كانوا 
من الذكور. كانت اأمرا�س العظام من اأكرث الأمرا�س التي مت علجها باخلارج، وكانت تايلند الوجهة املف�ضلة َتليها الهند )50 % و30 % 
على التوايل(. �ضافر 85َ% من املر�ضى للخارج للمعاجلة فقط، بينما �ضافر 10% منهم للمعاجلة وال�ضياحة معا، و 2.5% كانوا اأ�ضحاء 
15% من امل�ضاركني بالدرا�ضة �ضافروا مبا�رسة للخارج دون طلب ا�ضت�ضارة  اأن  ولكنهم �ضافروا لإجراء الفحو�ضات الطبية. من املده�س 
طبية داخل ال�ضلطنة. 38.2% من الذين متت معاينتهم يف ال�ضلطنة مل يكن هناك ت�ضخي�س حمدد، و38.2% اأخذوا علجا لكنه مل يكن 
فعال. ح�ضل 73% من امل�ضاركني يف العينة على معلومات من الأ�ضدقاء عن العلج باخلارج، وكانت مكاتب ال�ضياحة الطبية وال�ضبكة 
الدولية اأقل امل�ضادر ا�ضتخداما. ح�ضلت م�ضاعفات بعد العلج يف اخلارج عند 15% من املر�ضى.اخلال�صة: ينبغي تعميم احلقائق املختلفة 
حول العلج يف اخلارج يف املجتمع، وهذا ي�ضتوجب جهودا اأكرب يف تعزيز ال�ضحة العامة والتثقيف ال�ضحي.
مفتاح الكلمات: ُعمان، ال�ضياحة الطبية، نظام الرعاية ال�ضحية.
abstract: Objectives: This study aimed to understand why people seek medical advice abroad given the 
trouble and expense this entails. The types of medical problems for which treatment abroad was sought, preferred 
destinations and satisfaction with the treatment were explored. A secondary aim was to give feedback to stakeholders 
in the health care system on how to handle this issue and meet the needs of the community. Methods: 45 patients 
who had recently travelled abroad for treatment were asked to complete a questionnaire or were interviewed by 
telephone. Results: 40 questionnaires were received. 68% of the respondents were male. Orthopaedic diseases 
were the most common conditions leading patients to seek treatment abroad. Thailand was the most popular 
destination followed by India (50% and 30% respectively). 85% of respondents went abroad for treatment only, 
10% for treatment and tourism and 2.5% were healthy, but travelled abroad for a checkup. Interestingly, 15% of the 
participants went abroad without first seeking medical care locally. Out of those initially treated in Oman, 38.2% 
had no specific diagnosis and 38.2% had received treatment, but it was not effective. 73% of respondents obtained 
information on treatment abroad from a friend. The Internet and medical tourism offices were the least used sources 
of information. 15% of the patients experienced complications after their treatment abroad. Conclusion: Various 
facts about medical treatment abroad need to be disseminated to the public. This will necessitate greater effort in 
public health promotion and education.
Keywords: Oman; Medical tourism; Health care system.
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CLINICAL & BASIC RESEARCH
Advances in Knowledge
1. Medical tourism abroad is a growing phenomenon that needs to be addressed carefully by health care authorities in Oman.
2 Public misconceptions about the standards of treatment abroad need to be addressed by extensive health education.
Applications to Patient Care
1. Patients interested in going abroad for medical treatment need to be handled prudently by their treating physician.
2 Patients who insist on going abroad for a second opinion need to be appropriately guided and provided with all the relevant clinical data 
and evidence based medical information.
Medical Tourism Abroad 
A new challenge to Oman’s health system - the Al Dakhilya region experience
478 | SQU Medical Journal, November 2011, Volume 11, Issue 4
In a globalising world, health care is no longer confined within national borders. Medical tourism is a new term used to describe 
the practice of seeking medical care abroad for non-
emergency conditions. There is not yet an agreed 
international term for a person who travels abroad 
to seek medical treatment. Some experts label such 
patients “health tourists” or “medical tourists”. 
However, these terms suggests that travel abroad is 
for pleasure, which is at odds with the anxiety and 
pain often involved in seeking medical treatment. 
Therefore some prefer to refer to “medical travellers” 
even though the person might decide to combine 
his/her medical treatment abroad with tourism. 
Globalisation has prompted countries to 
evaluate their position on trade in health services.1-5 
The full extent of this trend is yet unknown, as data 
are sparse and anecdotal due to the absence of an 
internationally agreed definition and of a common 
methodology for data collection. This means that 
the limited statistics on medical tourism are often 
not comparable across countries; however, the 
available observations suggest that a substantial 
number of patients do travel to other countries 
for health care. For example, it is reported that 
Malaysia received 360,000 foreign patients from the 
Association of Southeast Asian Nations (ASEAN) 
region in 2007.6 According to a study by the World 
Health Organization’s (WHO) Regional Office 
for the Eastern Mediterranean, each year Jordan 
treats more than 120,000 non-Jordanian patients, 
generating an estimated US$ 1 billion in annual 
revenue.7 Regarding the number of residents from 
the USA travelling abroad for health services, a 
study by  Deloitte Consulting estimated that 750,000 
Americans travelled abroad for health services 
in 2007 and that this number would increase to 
1.6 million by 2012.8 A study by the consulting 
firm, McKinsey, estimated that the number of US 
residents travelling abroad for medical care was 
estimated to range between 5,000 and 750,000 
depending on the definition of medical travel.9
In Oman, there is a national committee for 
treatment abroad which decides on the eligibility 
of candidate patients. The number of people it 
sent for treatment abroad was only 20 per 100,000 
of the population in 2010 (so approximately 610 
persons),  down from about 59 per 100,000 in 
1977 (information provided in email by the MOH’s 
Department of Treatment Abroad). The decline 
in numbers reflects the diminishing importance 
of treatment abroad following the development of 
health services in Oman. The total expenditure on 
treatment abroad by the Ministry of Health (MOH) 
in Oman in 2003 was US$ 2,563,171. Patients are 
sent to the UK (London), India and Germany.10 It 
was out of the scope of this study to measure the 
magnitude of medical tourism in Oman or even in 
Dakhilya region due to unavailability of statistics.
If this trend continues, experts are convinced 
that it will have major implications for public health 
systems around the globe. Despite the growing 
importance of medical travel, we still have little 
empirical evidence about its impact on public 
health, especially on health systems.1 The medical 
community in developed countries has started to 
recognise medical tourism as a real phenomenon 
that impacts the profession, practitioners and 
patients. Peer-reviewed medical and health journals 
began publishing papers on this topic in 2006.11 The 
medical tourism marketplace consists of a growing 
number of countries competing for patients by 
offering a wide variety of medical, surgical, and 
dental services. Some of the medical tourism 
companies hook patients up with a hospital and 
surgeon, arrange for their family doctors to send 
records and consult with the surgeons overseas, 
make travel arrangements and book hospital 
admissions.12
They are many motivators for seeking treatment 
abroad such as: 1) Increased access to information 
about foreign health providers through the new 
developments in information technology; 2) Lower 
international transportation costs; 3) Reduced 
language barriers due to globalisation; 4) Treatments 
unavailable in the home country for legal, cultural 
or other reasons such as injections of stem cells; 5) 
Long waiting lists for certain procedures (UK and 
Canada),1 and 6) Inappropriate health insurance 
coverage (USA).12,13 However, researchers also found 
some barriers to medical tourism like the financial 
cost, fear of the unfamiliar and lack of confidence 
in foreign health care systems, discouragement by 
family doctors or treating physicians, and feeling 
too ill to travel.14
Customers of medical tourism companies can 
purchase anything from cosmetic procedures and 
diagnostic examinations to kidney transplants, in 
vitro fertilisation, cancer therapies, and orthopaedic 
procedures. The cost of medical tourism packages 
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varies greatly. The prices depend on the types 
of procedures, where patients travel, how long 
they intend to stay, and whether they choose 
postoperative accommodation in budget hotels or 
luxury resorts.15 
Medical travel has also raised several ethical 
issues. This is more evident when there are 
differential health policies in a particular country, 
i.e. one for the citizens as a public service and 
another standard for foreigners coming in as 
paying clients. Informed consent is a key ethical 
and legal issue as medical tourism companies are 
obliged to explain to patients the risks and benefits 
of medical procedures abroad.8 The potential 
exacerbation of health inequities in destination and 
source countries and the disruption of continuity 
of care for patients are other ethical concerns. 
The International Conference on Ethical Issues in 
Medical Tourism (ICEMT) raised three key points: 
1) Medical tourism has the potential for cross- or 
inter-disciplinary research; 2) Medical tourism 
research must engage with empirical research from 
a variety of disciplines, and 3) Ethical analyses of 
medical tourism must incorporate both individual 
and population-level perspectives.16
Many countries, especially in the Far East, 
invest in this emerging industry in order to build 
a modern medical infrastructure that will attract 
foreigners and will create a new source of income 
while improving the medical services provided 
to the local community.17 To respond to the 
growth in medical travel, many countries have 
set guidelines and accreditation tools to regulate 
its quality. Examples are the Joint Commission 
(formerly the Joint Commission on Accreditation 
of Health Care Organizations) which initiated the 
Joint Commission International (JCI) to accredit 
hospitals worldwide,18 and the standards framework 
for regulating the medical tourism industry and 
Statement on Medical and Surgical Tourism.19,20 
These tools address a number of concerns about 
this new industry and some of the safety and quality 
issues that patients may encounter if they seek 
health care services abroad.
The objectives of this study are thus threefold: 
first, to provide an overview of the main reasons 
and trends of patients travelling across borders from 
the Dakhilya region of Oman and their preferred 
destinations; second, to analyse the satisfaction 
rating of local treatment compared with that 
received abroad. Third, it aims to present the main 
challenges and areas for improvement for the health 
system and public health stakeholders in Oman as 
regards medical tourism.
Methods
The study was conducted in Al Dakhilya region 
(in north central Oman) between March 2009 
and August 2010. A questionnaire about medical 
tourism was developed after a literature review 
and discussion with colleagues in the Directorate 
General of Health Services, Dakhilya Region. 
The questionnaire was composed of two 
sections. Section one collected demographic and 
other data (including age, sex, place of residence, 
date of diagnosis in Oman, date of treatment abroad 
and the country where treatment abroad took 
place). Section two had questions on the reasons 
for treatment abroad, its costs, quality and the 
outcome of the treatment and finally which part of 
the body needed treatment. The questionnaire was 
distributed to all those who travelled abroad for 
health care during above period. The subjects, who 
were mainly employees and all from the Dakhilya 
region, were enrolled in the study when they 
came to the Department of Health Affairs in the 
Directorate General of Health Services in Nizwa 
for countersignature of their sick leave permission 
from their places of work in order to travel abroad 
for treatment. Verbal consent was taken from 
participants for participation in the study and they 
were assured that refusal would not lead to any 
adverse consequences. Most of the subjects were 
given the questionnaire for completion. A few were 
interviewed by telephone when the person who 
came to obtain the sick leave countersignature was 
not the patient. The Omani National Treatment 
Abroad Committee pays the expenses of treatment 
of those patients sent by the government. Those 
going by themselves are not reimbursed. Those who 
were sent abroad for treatment by the government 
were excluded from this study because it was 
not their decision to travel abroad for treatment, 
therefore their answers as to reasons for travel, 
destinations and satisfaction would be biased. The 
data were analysed using the Statistical Package 
for the Social Sciences (SPSS, Chicago, IL, USA, 
Version 16). The chi square statistical test was used 
and the P value set at < 0.05. The study protocol 
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was approved by the Medical Research and Ethics 
Committee of the Directorate General of Health 
Services, Al Dakhilya region.
Results
Out of 45 forms distributed, 40 forms were 
completed, returned and analysed (response 
rate 89%). All were completed by Omanis. Using 
descriptive analysis, the mean age of the study 
population was 38 years. The highest percentage of 
respondents was in the age group 31–40 years (31%). 
More males went abroad for treatment (67.5%) than 
females (32.5%). A total of 50% of the participants 
went to Thailand for treatment followed by India 
(30.0%), Iran (10.0%), Bahrain (7.5%) and United 
Arab Emirates (UAE) 2.5%. As to the distribution 
of clients according to their reason of travel, 85% 
of the participants travelled abroad to get treatment 
only; 10% for both treatment and tourism; 2.5% for 
a check-up, and another 2.5% for other reasons. 
About 85% of the study sample was treated in 
Oman before going abroad for treatment; thus, 15% 
went straight abroad for treatment without seeking 
treatment locally. The results of treatment of those 
treated inside Oman first are shown in Figure 1a.  A 
total of 38.2% of the participants did not receive a 
specific diagnosis in Oman, and also 38.2% of the 
participants received treatment, but they did not 
find it beneficial.
More than 70% of the participants in the study 
got information about health institutions abroad 
from their friends and 18.9% from their family 
[Figure 1b].  The highest percentage of respondents 
went abroad for treatment for orthopaedic diseases 
followed by neurological and then ophthalmological 
disease [Table 1]. Using univariate analysis, those 
people aged 30–40 years had the most orthopaedic 
diseases (41.7%) followed by those aged 41–50 
years (33.3%). Neurological diseases were also more 
prevalent in both age groups 31-40 and 41-50 years 
old compared to other age groups. Eye diseases 
were apparently more prevalent among people over 
50 years old; however, due to the small sample size, 
the association between age and type of diseases (P 
= 0.494) was not statistically significant.
Male subjects went for treatment abroad 
mainly for orthopaedic diseases (28%), neurological 
diseases (28%) and gastroenterological diseases 
(24%). Females went for treatment abroad for 
orthopaedic diseases (38.5%), eye diseases (38.5%) 
and neurological diseases (15.4%). The association 
between type of disease and sex (P = 0.116) was, 
however, not statistically significant.
About one third of the participants stayed 
abroad for one week for treatment while 25% of the 
participants stayed 1–2 weeks. Those participants 
who travelled for orthopaedic, gastroenterological 
and neurological diseases preferred going to 
Thailand while those participants who sought 
treatment for eye diseases preferred to go to Iran; 
participants who sought treatment for cardiac 
Figure 1a: Distribution of subjects according to result 
of treatment inside Oman.
Figure 1b: Distribution of subjects according to source 
of information about health institutions outside Oman.
Table 1: Distribution of subjects according to type of 
disease
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diseases preferred to go to India. The association 
between type of diseases and country (P = 0.051) 
was, however, not statistically significant.
Concerning cost, more than 60% of the 
participants spent less than 2,000 Omani rials (c. 
US $ 5,200) for treatment abroad while 38% of the 
participants in the study spent more than 2,000 Omani 
rials [Figure 2]. A total of 45% of the participants 
who went to Thailand spent more than 2,000 Omani 
rials and 41.7% of the participants who went to India 
also spent more than 2,000 Omani rials whereas 
75% of the participants who went to Iran spent 
1,000–1,500 Omani rials. The association between 
the cost of treatment and the country of treatement 
(P = 0.249) was, however, not statistically significant.
We found that the percentage of satisfaction 
about treatment abroad was 100% in all countries 
except India where it was 83.3% giving an overall 
satisfactory percentage of 95%. There was no 
association between satisfaction with treatment 
and country (P = 0.296). A total of 15% of the 
participants developed some complications related 
to the treatment. These complications include pain, 
allergy, swelling and high blood pressure. Half of 
the participants had follow-up in governmental 
health institutions after coming back from abroad 
with 55% of them getting better [Figure 3].  Visits 
to Bahrain produced the highest percentage of 
treatment complications (33.3%) followed by 
India (16.7%) and Thailand (15%). The association 
between treatment complications and country (P = 
0.685) was, however, not statistically significant. 
Discussion
The sample size of this study was relatively small 
due to the difficulty of enrolling in the study those 
who travelled abroad for treatment because of the 
unavailability of a database. Nevertheless it revealed 
some interesting findings. Men travelled more than 
women probably since they are able to travel alone, 
while women, following Islamic and traditional 
customs, usually need a male companion. The 
overall mean age was 38 years which means that 
people tend to seek medical care abroad while they 
are young.
Due to low medical care costs in south Asian 
countries, India and Thailand were the most 
popular destinations for treatment abroad. This is 
contrary to a study of Saudi patients who travelled 
abroad for renal transplantation where the majority 
of transplant tourists obtained their kidneys in 
Pakistan (49%) followed by the Philippines (28%), 
Egypt (11%), and the United States (3.2%).21 
Although the majority of patients went for 
treatment only, it is interesting that some of them 
(10%) went for tourism as well. The explanation 
could be explained that they initially decide to go 
for tourism and then decide to obtain a medical 
check-up at the same time. This decision could also 
be influenced by the long delays and waiting lists at 
home. A study on reproductive health tourism in 
the United Arab Emirates (UAE) found that another 
reason for travel is privacy; this is a concern in an 
environment where both infertility and in vivo 
fertilisation are still stigmatised.22
One of the interesting findings in our study is 
that 15% of the participants did not even seek any 
medical care locally, but rather travelled abroad 
directly although their illness could have been 
Figure 2: Distribution of subjects according to cost of 




























Figure 3: Distribution of subjects according to 
evaluation by Omani government doctors after return 
to Oman.
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managed locally. The reasons for such trend was 
not clear from this study so further studies may be 
necessary in future in order to explore this issue 
specifically. 
Although dissatisfaction with local treatment 
was thought to be a major reason for seeking 
treatment abroad, this study showed only 5.9% 
of the participants were dissatisfied with local 
treatment. Concerning their source of information 
on treatment abroad, the Internet, newspapers and 
medical tourism offices were the least used sources 
(2.7% each); these are all available in Oman, but their 
low usage would indicate that people still intend to 
use traditional methods (such as word of mouth) as 
their source of information.
Although one may think that medical care 
abroad is cheap, overall costs are high. One third 
of participants in this study paid more than 2,000 
Omani rials (c. US $ 5,200) for their treatment. This 
may give an insight into how much people may be 
ready to spend on their health. A case report from 
Bahrain showed that the prescription of 19 drugs, 
many of equivocal benefit, at a monthly estimated 
cost of US $ 615 imposed a substantial economic 
burden on the patient and led to poor adherence 
due to the confusing drug regimen.23
While it is thought that treatment abroad does 
not lead to complications, this study revealed 
that 15% of the participants indeed suffered some 
complications. This percentage may also be an 
underestimation since people may prefer not to 
report problems so as not to be blamed for seeking 
medical care outside their country. In addition, 
some complications do not manifest immediately; 
however, the subjects in this study responded to 
the questionnaire within days or at a maximum 2 
weeks after their return from treatment abroad. 
Alghamdi et al. in 2010 showed that the group 
of ‘transplant tourists’ had a significantly higher 
rate of acute rejection within the first year 
compared with those who underwent local 
transplantation (27.9% versus 9.9%, P = 0.005). Also, 
compared with local transplantation, transplant 
tourists had a higher rate of cytomegalovirus 
(CMV) infections (15.1% versus 5.6%, P = 0.05) 
and hepatitis C seroconversion (7.5% versus 
0%, P = 0.02).21 In 2011, Al Khaja reported on a 
Bahrani patient who experienced adverse effects 
due to the polypharmacy prescribed abroad; 
these included nausea, vomiting, gastric pain, 
flatulence, severe constipation, tiredness, 
palpitation, nervousness and dizziness which 
compromised the patient’s quality of life and 
resulted in poor medication compliance.23
The most popular specialty for which people 
sought medical care abroad in this study was 
orthopaedics. This could be explained by the 
chronic nature of such diseases, its high prevalence, 
especially among the elderly, and the scarcity of 
specialist clinics in each health institution or region 
of Oman. 
The limitations of this study included scarcity of 
data and statistics on patients who travelled abroad 
for treatment; this resulted in a small sample size. 
A further limitation is the shortage of scientific 
literature about medical tourism in Arab and 
Arabian Gulf countries. Further studies in these 
various countries, individually or as multicentre 
studies, are required to obtain a clearer picture of 
the treatment abroad trend.
Conclusion
This study has shown that it is very difficult to obtain 
data on patients who travel abroad for treatment. 
This therefore necessitates the establishment 
of national registries and databases. Many facts 
regarding medical tourism should be made clear 
to the community (e.g. treatment abroad can have 
some complications, is costly and that consultation 
with a local doctor is necessary prior travel). Modern 
technological methods for accessing information 
sources should also be advocated (i.e. Internet). 
Health education about the treatment of chronic 
diseases should be intensified so that people can 
decide whether there is chance for their illness to 
get cured abroad or not. 
Specifically, two different approaches can be 
used to respond to the issues which this study raises 
in Oman about medical treatment abroad: the 
public health sector approach and the community 
approach. 
First, the Omani public health authorities 
(the MOH and its sister institutions) need to 
pay more attention to this trend by establishing 
a national database and registry of treatment 
abroad which should be regular audited. Second, 
Omani authorities, in conjunction with those in 
the destination countries, should 1) Set standards 
as a framework for regulating the medical tourism 
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industry and encourage other countries to do so; 
2) Accredit medical tourism companies and then 
regularly review their accreditation; 3) Mandate 
medical tourism companies to contribute to 
funds to protect clients from financial losses and 
to compensate them in case of complications or 
medical errors.1,5,12 Scientific conferences and 
workshops organised with other Gulf Cooperation 
Council (GCC) countries should also be encouraged 
in order to empower researchers and scientists to 
understand this phenomenon in our immediate 
region.
As to the community approach, the aim 
would be to raise awareness through the various 
media among all age groups in the community 
about medical tourism and its implication for 
individuals, families, communities and countries. 
Since it was shown clearly by our study that data 
and statistics about medical tourists are limited 
and difficult to trace, people should be requested 
to report to their primary health care institution on 
their return for recording and follow-up. Patients 
planning on medical tourism should know that 
they need to consult their local doctors first, use 
modern technologies (e.g. the Internet for browsing 
destinations options and offers), and be aware 
that complications can occur in treatment abroad. 
This awareness raising and education would be 
better undertaken as a multidisciplinary effort by 
various ministries, agencies and non-governmental 
organisations (NGOs).
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